Neurolief, a global leader in medical devices delivering groundbreaking neurotechnology innovations for the treatment of Neurological and Neuropsychiatric disorders, is pleased to announce a strategic equity...
Profound Medical Corp. announced the pricing of its previously announced underwritten public offering of 2,666,667 common shares at a price to the public of US$7.50 per...
NeuroSense Therapeutics Ltd. announced that it has received a notification from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) advising the Company that...
Cyclo Therapeutics, Inc. and Applied Molecular Transport Inc. announced the closing of its previously announced transaction pursuant to which AMT will merge with Cyclo Therapeutics in...
Natera, Inc. announced that the federal District Court for the Middle District of North Carolina has issued a preliminary injunction, effective immediately, enjoining the RaDaR assay...
LiveCare Inc. is thrilled to announce significant expansions in its service reach, the addition of a prominent medical expert to its team, and remarkable achievements by...
Inspira Technologies OXY B.H.N. Ltd. announced that it has entered into a definitive agreement for the issuance and sale of an aggregate of 3,031,250 of ordinary...
Community Health Systems, Inc. announced the early tender results of the previously announced cash tender offer by its wholly owned subsidiary, CHS/Community Health Systems, Inc., to...
EverGlade Consulting, has helped ModeX Therapeutics successfully secure up to $168 million in funding through a contract with the Biomedical Advanced Research and Development Authority (“BARDA”)...
Axogen, Inc. is pleased to announce the appointment of Kathy Weiler to its Board of Directors, effective December 20, 2023. Weiler, a senior executive with 20+...
Procaps Group, S.A. announced its financial results for the three months ended September 30, 2023 (“3Q23”) and the nine months ended September 30, 2023 (“9M23”). Financial...
HORIBA STEC, Co., Ltd., is to build a new factory in Fukuchiyama City, Kyoto Prefecture, to manufacture HORIBA Semiconductor’s mainstay products such as mass flow controllers...
HiMedia Laboratories announces that its RT-PCR kits are capable of detecting the recently discovered JN.1, SARS-CoV-2 variant. The portfolio includes: MBPCR243 – Hi-PCR® Coronavirus (COVID-19) Multiplex...
Longeveron Inc. announced the closing of its previously announced registered direct offering, priced at-the-market under Nasdaq rules, for the purchase and sale of 1,355,301 shares of...
Recently, Panlin Capital announced that Hangzhou Panlin Xukang Fund has completed its second closing. This is the first fund that Panlin Capital has established in Hangzhou...
Copyright © 2024 Medical Buyer